By Gina Shaw
In light of record high demand and ongoing supply challenges for pediatric fever-reducing medications, the FDA has issued immediate guidance on compounding ibuprofen oral suspension products for pediatric patients with fever and adults who are unable to swallow solid oral dosage forms.
JANUARY 26, 2023